...
首页> 外文期刊>Pharmacognosy magazine >In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
【24h】

In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ

机译:活化过氧化物酶体增殖物激活受体γ的37种中药的体外筛选与评价

获取原文
           

摘要

Background: Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous severe side-effects may also occur concomitantly. Objective: The PPARγ activation activity of different polar extracts, including petroleum ether, ethyl acetate, n-butanol, residual of ethanol, the precipitate part of water and the supernatant of water extracts, from 37 traditional Chinese medicines were systematically evaluated. Materials and Methods: HeLa cells were transiently co-transfected with the re-constructed plasmids of GAL4-PPARγ-ligand binding domain and pGL4.35. The activation of PPARγ by different polarity extracts were evaluated based on the PPARγ transactivation assay and rosiglitazone was used as positive control. Results: Seven medicines (root bark of Lycium barbarum, Anoectochilus sroxburghii , the rhizome of Phragmites australis, Pterocephalus hookeri, Polygonatum sibiricum , fruit of Gleditsia sinensis , and Epimedium brevicornu ) were able to significantly activate PPARγ. Conclusion: As seven medicines were able to activate PPARγ, the anti-diabetic activity of them is likely to be mediated by this nuclear receptor. SUMMARY Lots of the tested medicinal products had activation effects on activating PPARγ Ethyl acetate extracts of root bark of L.barbarum , rhizome of P.saustralis and fruit of G.siasinensis showed good PPARγ activation effect similar or higher than that of positive control, 0.5 μg/mL rosiglitazone Petroleum ether extracts of A.roxburghii , P. hookeri , P. sibiricum , E.brevicornu also can significantly activate PPARγ, the effects of them were higher than t0.5 μg/mL rosiglitazone Schisandra chinensis (Turcz.) Baill., the fruit Cornus officinalis Siebold and Zucc., Alisma plantago-aquatica L . and the root of Trichosanthes Kirilowii Maxim., traditional anti-diabetic mediciness in China, had no effects on the activation of PPARγ. Abbreviations used : PPARγ: Peroxisome Proliferator-activated Receptors-γ, TCMs: Traditional Chinese medicines, TZDs: Thiazolidinediones, LBD: Ligand binding domain, DMSO: Dimethyl sulfoxide, FBS: Fetal bovine serum, DMEM: Dulbecco's modified Eagle's medium.
机译:背景:过氧化物酶体增殖物激活受体(PPAR)-γ被广泛用作治疗2型糖尿病的引人注目的靶标。噻唑烷二酮是PPARγ的激动剂,已广泛用作2型糖尿病的胰岛素增敏剂,但同时也可能出现许多严重的副作用。目的:系统评价37种中药不同极性提取物的极性,包括石油醚,乙酸乙酯,正丁醇,乙醇残留,水的沉淀部分和水提取物的上清液。材料与方法:将HeLa细胞与GAL4-PPARγ-配体结合域和pGL4.35的重组质粒瞬时共转染。基于PPARγ反式激活试验评估了不同极性提取物对PPARγ的激活作用,并将罗格列酮用作阳性对照。结果:七种药物(枸杞的根皮,金线莲,芦苇的根状茎,钩头蕨,黄精,西伯利亚的果实和淫羊Epi)能够显着激活PPARγ。结论:由于七种药物能够激活PPARγ,因此它们的抗糖尿病活性可能是由这种核受体介导的。总结许多受试药物对激活PPARγ均具有激活作用,其提取物为L.barbarum根皮,桔梗根茎和G.siasinensis果实,具有良好的PPARγ激活作用,与阳性对照相似或更高,为0.5。罗格列酮微克/毫升罗格列酮,钩形假单胞菌,西伯利亚黄瓜,短螺旋体的石油醚提取物也能显着激活PPARγ,其作用高于t0.5微克/毫升罗格列酮五味子。 ,水果山茱off厚朴和Zucc。,泽泻车前草-水生。而中国传统的抗糖尿病药物天花粉(Trichosanthes Kirilowi​​i Maxim)的根对PPARγ的活化没有影响。使用的缩写:PPARγ:过氧化物酶体增殖物激活受体-γ,TCM:中药,TZD:噻唑烷二酮,LBD:配体结合域,DMSO:二甲基亚砜,FBS:胎牛血清,DMEM:Dulbecco改良的Eagle培养基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号